It is appealing to suggest that ASCL1 and FGF12 methylation might have diagnostic potential (ability to discriminate between tumor and normal tissues) in both colorectal and endometrial cancer or reflect similarities in the biology underlying these cancer types. Here, FGF12 is linked to endometrial cancer.